Most successful vaccines elicit neutralizing antibodies and this property is a high priority when developing an HIV vaccine. Indeed, passively administered neutralizing antibodies have been shown to protect against HIV challenge in some of the best available animal models. For example, antibodies given intravenously can protect macaques against intravenous or mucosal SHIV (an HIV/SIV chimaera) challenge and topically applied antibodies can protect macaques against vaginal SHIV challenge. However, the mechanism(s) by which neutralizing antibodies afford protection against HIV is not understood and, in particular, the role of antibody Fc-mediated effector functions is unclear. Here we report that there is a dramatic decrease in the ability of a broadly neutralizing antibody to protect macaques against SHIV challenge when Fc receptor and complement-binding activities are engineered out of the antibody. No loss of antibody protective activity is associated with the elimination of complement binding alone. Our in vivo results are consistent with in vitro assays indicating that interaction of Fc-receptor-bearing effector cells with antibody-complexed infected cells is important in reducing virus yield from infected cells. Overall, the data suggest the potential importance of activity against both infected cells and free virus for effective protection against HIV.

CD38, a type II transmembrane glycoprotein highly expressed in hematological malignancies including multiple myeloma (MM), represents a promising target for mAb-based immunotherapy. In this study, we describe the cytotoxic mechanisms of action of daratumumab, a novel, high-affinity, therapeutic human mAb against a unique CD38 epitope. Daratumumab induced potent Ab-dependent cellular cytotoxicity in CD38-expressing lymphoma- and MM-derived cell lines as well as in patient MM cells, both with autologous and allogeneic effector cells. Daratumumab stood out from other CD38 mAbs in its strong ability to induce complement-dependent cytotoxicity in patient MM cells. Importantly, daratumumab-induced Ab-dependent cellular cytotoxicity and complement-dependent cytotoxicity were not affected by the presence of bone marrow stromal cells, indicating that daratumumab can effectively kill MM tumor cells in a tumor-preserving bone marrow microenvironment. In vivo, daratumumab was highly active and interrupted xenograft tumor growth at low dosing. Collectively, our results show the versatility of daratumumab to effectively kill CD38-expressing tumor cells, including patient MM cells, via diverse cytotoxic mechanisms. These findings support clinical development of daratumumab for the treatment of CD38-positive MM tumors.

Time-Resolved Holography with Photoelectrons

The performance of infrared (IR) spectroscopy of gas-phase ions in a commercially available 7 T Fourier transform ion cyclotron resonance mass spectrometer has been characterized. A pi-allyl-palladium reactive intermediate, [(pi-allyl)Pd(P(C6H5)3)2]+, involved in the catalytic allylation of amine is studied. A solution of this transition metal complex is electrosprayed, and the IR multiple photon dissociation (IRMPD) spectrum of the mass-selected ions is recorded in two spectral ranges. The fingerprint spectrum (650-1550 cm(-1)) is recorded using the Orsay free-electron laser, and the dependence of the IRMPD efficiency on laser power and irradiation time is characterized. The DFT-calculated IR absorption spectrum of the [(pi-allyl)Pd(P(C6H5)3)2]+ complex shows good agreement with the experimental spectrum. The pi-interaction between the palladium and the allyl moiety is reflected by the assignment of the IRMPD bands, and the observed allylic CH2 wagging modes appear to form a sensitive probe for the pi-interaction strength in metal-pi-allyl complexes. This spectral assignment is further supported by the analysis of the different IRMPD photofragmentation patterns observed at different photon energies, which are found to result from wavelength-specific photofragmentations. Nine peaks are well-resolved in the experimental spectrum, for which the bandwidth (fwhm) is on the order of 15 cm(-1). Resonances with a calculated IR intensity of 5 km/mol or larger are shown to be amenable for IRMPD, indicating an excellent sensitivity of our new experimental setup. Finally, the IR spectrum has also been recorded in the CH stretching region (2950-3150 cm(-1)) using a tabletop IR optical parametric oscillator/amplifier (OPO/OPA) laser source.